Safety and efficacy of combined use of sildenafil, bosentan, and iloprost before and after liver transplantation in severe portopulmonary hypertension-Reference-Cited by-同舟云学术

Safety and efficacy of combined use of sildenafil, bosentan, and iloprost before and after liver transplantation in severe portopulmonary hypertension

Published:2008-02-27 Issue:3 Volume:14 Page:287-291
ISSN:1527-6465
Container-title:Liver Transplantation
language:en
Short-container-title:Liver Transpl

Author:

Austin Mark J.,McDougall Neil I.,Wendon Julia A.,Sizer Elizabeth,Knisely Alex S.,Rela Mohammed,Wilson Carol,Callender Michael E.,O'Grady John G.,Heneghan Michael A.

Publisher

Wiley

Subject

Transplantation,Hepatology,Surgery

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/lt.21310/fullpdf

Reference28 articles.

1. The distinct concepts and implications of hepatopulmonary syndrome and portopulmonary hypertension;Krowka;Crit Care Med,2005

2. Diagnosis of portopulmonary hypertension in candidates for liver transplantation: a prospective study;Colle;Hepatology,2003

3. Hepatopulmonary syndrome and portopulmonary hypertension: a report of the multicenter liver transplant database;Krowka;Liver Transpl,2004

4. Portopulmonary hypertension and the liver transplant candidate;Kuo;Transplantation,1999

5. Portopulmonary hypertension and hepatopulmonary syndrome;Hoeper;Lancet,2004

Cited by 92 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Liver in Systemic Disease;MacSween's Pathology of the Liver;2024

2. Risk factors for portopulmonary hypertension in patients with cirrhosis: a prospective, multicenter study;Hepatology International;2022-12-07

3. A brief history of liver transplantation and transplant anesthesia;BMC Anesthesiology;2022-11-26

4. Risk factors for portopulmonary hypertension in patients with cirrhosis: A prospective, multicenter study;2022-08-29

5. Portopulmonary hypertension: Current developments and future perspectives;Liver Research;2022-03